002626.SZ
Xiamen Kingdomway Group Co.
SZSE · Healthcare · C 制造业 · CN
CNY 18.10
+0.61%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.4B | 3.4B | 3.2B | 3.1B | 3.0B |
| Cost of Revenue | 2.1B | 2.0B | 2.0B | 1.9B | 1.8B |
| Gross Profit | 1.3B | 1.3B | 1.2B | 1.2B | 1.2B |
| Operating Expenses | |||||
| R&D Expense | 69.0M | 75.6M | 69.4M | 58.2M | 71.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 382.9M | 381.8M | 384.1M | 418.7M | 370.7M |
| Selling & Marketing Expense | 338.4M | 332.1M | 316.5M | 320.3M | 288.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 869.2M | 839.5M | 769.2M | 807.9M | 726.0M |
| Cost and Expenses | 2.9B | 2.9B | 2.8B | 2.8B | 2.5B |
| Operating Income (EBIT) | 312.0M | 379.0M | 482.3M | 356.0M | 312.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 311.0M | 377.7M | 469.5M | 334.6M | 310.7M |
| Income Tax Expense | 46.2M | 57.1M | 102.5M | 58.4M | 65.6M |
| Bottom Line | |||||
| Net Income | 283.8M | 339.9M | 342.0M | 276.7M | 257.4M |
| Earnings from Cont. Ops | 264.8M | 320.6M | 367.0M | 276.2M | 245.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 283.8M | 339.9M | 342.0M | 276.7M | 257.4M |
| Per Share | |||||
| Basic EPS | CN¥0.47 | CN¥0.56 | CN¥0.56 | CN¥0.45 | CN¥0.42 |
| Diluted EPS | CN¥0.47 | CN¥0.55 | CN¥0.56 | CN¥0.45 | CN¥0.42 |
| Revenue Per Share | CN¥5.62 | CN¥5.54 | CN¥5.31 | CN¥5.05 | CN¥4.91 |
| Shares | |||||
| Basic Shares Outstanding | 596.5M | 607.0M | 610.7M | 614.9M | 612.9M |
| Diluted Shares Outstanding | 596.5M | 607.0M | 610.7M | 614.9M | 612.9M |
| Profitability Metrics | |||||
| EBITDA | — | 554.7M | 652.9M | 527.9M | 489.8M |
| D&A | — | 175.7M | 170.6M | 171.9M | 177.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026